Biotech Boulevard
Startups and Spinouts
GEN's Biotech Boulevard highlights new entrepreneurial biotech firms based all over the globe. These unique companies are developing breakthrough products that will expand and enhance the biotech industry.
Discover, invest, and collaborate with these industry leaders of tomorrow.
Explore Biotech Boulevard. It's paved with opportunities!
GEN's Biotech Boulevard
All  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z   0  1  2  3  4  5  6  7  8  9   
  • Nabsys www.nabsys.com

    Nabsys is working on enabling advances in life sciences and healthcare through strategic deployment of a novel positional sequencing platform with broad applicability for DNA analysis. The Nabsys DNA analysis platform employs fully solid state nanodetectors that reveal both the identity and location of DNA sequences over long distances (10’s to 100’s of thousands of bases).  The technology employs electronic detection that permits the location of sequences to be identified in a highly accurate and rapid manner. This approach allows for the identification of sequence variants of all length scales applicable to diagnostics, agriculture and whole genome sequencing. 

  • NanoOncology www.nanoonc.com

    NanoOncology is a biotechnology company that was recently purchased by PeptiMed. Its mission is to identify specific tumor-causing genetic targets and designing small interfering RNA (siRNA)-based drugs and small molecules drugs that inhibit the tumor promoting function of gene products for each patient on an individual basis. The company invented EVIRNA ™, a proprietary siRNA therapeutic drug that targets the EVI1 gene for treatment of advanced breast, prostate, lung, colon, ovarian, and skin cancer. NanoOncology also invented a unique polypeptide-based nanoparticle system for delivery of siRNA directly to tumor cells.

  • NanoTemper Technologies www.nanotemper-technologies.com

    NanoTemper Technologies GmbH develops, produces and markets innovative, high quality instruments for bio-medical research. The company, a spin off from the University of Munich (LMU), has developed Microscale Thermophoresis (MST) a new technology for biomolecular interaction measurements. The company was founded in 2008 and it has been expanding globally ever since.

  • NanoViricides www.nanoviricides.com

    NanoViricides applies nanomedicine technologies to the treatment of viral diseases. The nanoviricide® has a peptide on its surface that the company designs which mimics what's expressed on the surface of the target cell of the virus. The attachment of the surface protein of the virus to the "mimic" causes a conformational change in the nanoviricide® which then encapsulates the virus, destroying it. This has been demonstrated in over 4000 animals with 9 different viral-induced diseases.

© 2012 Genetic Engineering & Biotechnology News. All Rights Reserved.
Back to www.genengnews.com